Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GS1-144 by Changchun Jinsai Pharmaceutical for Vasomotor Symptoms (Non-Menopausal): Likelihood of Approval
GS1-144 is under clinical development by Changchun Jinsai Pharmaceutical and currently in Phase I for Vasomotor Symptoms (Non-Menopausal). According to...